OncLive

Tumor Markers in CCA

Prognostic Factors in Acute Lymphoblastic Leukemia

Clinical Utility of Circulating Tumor Cells

Common Signs and Symptoms of Polycythemia Vera

Overview of Novel Therapy for Advanced-Stage NSCLC

Combination Therapy for Localized Prostate Cancer

Dr. Agarwal on PFS2 Data From the TITAN Trial in mCSPC

Dr. Corcoran on Targeting HER2 Amplification in CRC

Risk of Thrombosis in Patients With ITP

HER2+ Breast Cancer: Brain Metastasis Prevalence & Later-Line Therapy

Treatment Landscape of Castrate-Resistant Prostate Cancer

Dr. Rizvi on the Limitations of ABVD in Hodgkin Lymphoma

Dr. Forde on Updates to the TNM Staging System in Lung Cancer

The Use of Ruxolitinib in Myelofibrosis

Promising Data in CRC and Cholangiocarcinoma, European Approval in Myeloma, and More

Radiation Therapy in Renal Cell Carcinoma

EU Approval of Ixazomib for Relapsed/Refractory Myeloma

Pain Management in Prostate Cancer

Ibrutinib Updates, Priority Reviews in Sarcoma and ALL, European Approval in Sarcoma, and More

Prognostic Factors in Patients With CLL

FDA Approval in RCC, European Approvals in Myeloma and Melanoma, and 2016 AUA Highlights

Dr. Shayma Kazmi on Olanzapine for Breakthrough Chemotherapy-Induced Nausea and Vomiting

Biology of Clear Cell Renal Cell Carcinoma

Dr. Tsao on Rationale for Staging Renal Cell Carcinoma

OncLive News Network On Location: ASCO 2020 Day 1

FDA Approval in ALL, Priority Review in Hairy Cell Leukemia, European Approval in Myeloma, and More

Two Positive Phase III RCC Studies, Nivolumab Approved for NSCLC in Europe, and More

The Importance of Risk Assessment

Evolving Role of Trastuzumab Deruxtecan in HER2+/HER2-Low mBC

EGFR Exon 20 Mutations in Non–Small Cell Lung Cancer

Dr. Coleman on the VELIA Trial Impact on Ovarian Cancer Practice

Treating Patients With Essential Thrombocytopenia

Therapeutic Options for Advanced Prostate Cancer

Treating Non–Small Cell Lung Cancer With an EGFR Exon 20 Insertion

Cirrhosis Prognosis: The Child-Pugh Score

Dr. William Grady Discusses Molecular Subtypes in Colorectal Cancer

Lenalidomide in Del 5q MDS

Dr. Mutti on Role of Immunotherapy in Mesothelioma

Therapy Options for Hepatitis B/C–Related HCC

Dr. Seetharamu on Immunotherapy Treatment for Head and Neck Cancers

Early Salvage Radiotherapy for Early Prostate Cancer

MDS: Low-Risk Disease Treatment Options

New Options for Recurrent Ovarian Cancer

Dr. Lopes on the Rationale to Stop Immunotherapy After 2 Years in Lung Cancer

Paice on Current Pain Management for Breast Cancer

Novel Treatments in HER2-Positive Breast Cancer

Dr. Bruce D. Cheson Describes the Lymphoma Research Foundation

Diagnosis of Neurofibromatosis Type 1

Approaching HER2 Testing in Breast Cancer

Role of Phlebotomy in Polycythemia Vera

Dr. Sullivan Discusses Role of Dabrafenib Plus Trametinib in Melanoma